Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by PETERSEN-FELIX, S.
Right arrow Articles by ZBINDEN, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PETERSEN-FELIX, S.
Right arrow Articles by ZBINDEN, A. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1994, Vol. 73, No. 3 326-330
© 1994 The Board of Management and Trustees of the British Journal of Anaesthesia


research-article

Ondansetron does not inhibit the analgesic effect of alfentanil

S. PETERSEN-FELIX, MD, L. ARENDT-NIELSEN, PHD, P. BAK, MSCEE, P. BJERRING, MD, PHD, H. BREIVIK, MD, PHD, P. SVENSSON, DDS and A. M. ZBINDEN, MD, PHD

Department of Anaesthesiology and Intensive Care, University Hospital of Berne Switzerland
Department of Medical Informatics, University of Aalborg Denmark
Department of Dermatology, University Hospital of Aarhus Denmark
Department of Anaesthesiology, Rikshospitalet, University of Oslo Norway
Royal Dental College Aarhus, Denmark

Address for correspondence: Institut für Anästhesie und Intensivbehandlung, Inselspital, CH 3010 Berne, Switzerland

5-Hydroxytryptamine (5-HT) causes antinociception via presynaptic 5-HT3 (5-HT subtype 3) receptors on primary afferent nociceptive neurones in the spinal cord dorsal horn. Therefore, ondansetron (a 5-HT3 receptor antagonist) may increase the perception of a noxious stimulus or decrease the effects of concurrently administered antinociceptive drugs. Using a randomized, doubleblind, crossover study design, we have tested this hypothesis in eight healthy volunteers who, on three different days, received either ondansetron and placebo, ondansetron and alfentanil or placebo and alfentanil. Experimental pain was induced with heat, cold, mechanical pressure and electrical stimulation. Ondansetron alone did not change the response to any of the experimental tests, but alfentanil and the combination ondansetron- alfentanil significantly changed the response compared with ondansetron alone. There was no difference between alfentanil alone and the combination ondansetron-alfentanil. We conclude that ondansetron does not change the response to pressure, heat, cold or electrical nociceptive stimuli or antagonize the analgesic effect of alfentanil.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
A. Paraskeva, V. Chatziara, I. Siafaka, M. Zotou, and A. Fassoulaki
Ropivacaine Spinal Anesthesia Is Not Antagonized by Ondansetron Pretreatment
Anesth. Analg., November 1, 2009; 109(5): 1684 - 1687.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Rantanen, H. Ypparila-Wolters, M. van Gils, A. Yli-Hankala, M. Huiku, M. Kymalainen, and I. Korhonen
Tetanic stimulus of ulnar nerve as a predictor of heart rate response to skin incision in propofol remifentanil anaesthesia
Br. J. Anaesth., October 1, 2007; 99(4): 509 - 513.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. A. Scott, M. Wood, and P. Flood
The pronociceptive effect of ondansetron in the setting of p-glycoprotein inhibition.
Anesth. Analg., September 1, 2006; 103(3): 742 - 746.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Fassoulaki, A. Melemeni, M. Zotou, and C. Sarantopoulos
Systemic Ondansetron Antagonizes the Sensory Block Produced by Intrathecal Lidocaine
Anesth. Analg., June 1, 2005; 100(6): 1817 - 1821.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
D. L. Keefe
The Cardiotoxic Potential of the 5-HT3 Receptor Antagonist Antiemetics: Is There Cause for Concern?
Oncologist, February 1, 2002; 7(1): 65 - 72.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.